PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11294500-0	2001	Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.	vanadyl sulfate	59-74	neuropeptide Y	Rattus norvegicus	25-39	
11294500-1	2001	In an attempt to elucidate the effect of vanadium compounds on the gene expression of neuropeptide Y (NPY), vanadyl sulfate (VOSO4) was orally administrated at the dose of 1 mg/kg body weight into streptozotocin-induced diabetic rats (STZ-diabetic rats) three times daily for 1 week.	vanadyl sulfate	108-123	neuropeptide Y	Rattus norvegicus	86-100	
11294500-1	2001	In an attempt to elucidate the effect of vanadium compounds on the gene expression of neuropeptide Y (NPY), vanadyl sulfate (VOSO4) was orally administrated at the dose of 1 mg/kg body weight into streptozotocin-induced diabetic rats (STZ-diabetic rats) three times daily for 1 week.	vanadyl sulfate	108-123	neuropeptide Y	Rattus norvegicus	102-105	
11294500-1	2001	In an attempt to elucidate the effect of vanadium compounds on the gene expression of neuropeptide Y (NPY), vanadyl sulfate (VOSO4) was orally administrated at the dose of 1 mg/kg body weight into streptozotocin-induced diabetic rats (STZ-diabetic rats) three times daily for 1 week.	vanadyl sulfate	125-130	neuropeptide Y	Rattus norvegicus	86-100